Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.02501 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.00842 | 82 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.1479 | 83 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.22101 | 83 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.12207 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.13807 | 85 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.09262 | 84 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.12867 | 84 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.1265 | 83 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.22722 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.1847 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.12988 | 83 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.14124 | 83 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.13458 | 84 |